Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.
Recce Pharmaceuticals Ltd has officially applied for the quotation of 35,381 new ordinary fully paid securities, as announced on May 10, 2024. This action, aligning with the ASX Listing Rules, demonstrates the company’s intent to expand its financial horizons on the Australian Securities Exchange.
For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.